目次

1. Introduction to Cancer Vaccines

2. Mechanism of Cancer Vaccines
2.1 Idiotype Cancer Vaccine Mechanism
2.2 Cellular Cancer Vaccines Mechanism
2.3 Ganglioside Antigens based Cancer Vaccines Mechanism
2.4 Peptide Cancer Vaccine Mechanism
2.5 Tumor Host Interaction Cancer Vaccine Mechanism

3. Global Cancer Vaccine Market Overview
3.1 Current Market Scenario
3.2 Future Market Opportunity

4. Cancer Vaccine Market Insight by Region
4.1 US
4.2 Europe
4.3 China
4.4 Japan
4.5 India
4.6 South Korea
4.7 Australia
4.8 Cuba
4.9 Canada
4.10 UK

5. Cancer Vaccine Market Insight by Indication
5.1 Human papillomavirus Associated Cancer
5.2 Lung Cancer
5.3 Pancreatic Cancer
5.4 Prostate Cancer
5.5 Bladder Cancer
5.6 Melanoma
5.7 Breast Cancer
5.8 Colorectal Cancer
5.9 Glioblastoma
5.10 Ovarian Cancer

6. Approved Cancer Vaccines - Price, and Dosage Analysis

7. This Chapter Give Insight On 11 Cancer Vaccine Commercially Available In Market

8. Global Cancer Vaccines Clinical Pipeline Overview
8.1 7.1 By Company
8.2 7.2 By Country
8.3 7.3 By Patient Segment/Disease Stage
8.4 7.4 By Phase

9. Global Cancer Vaccines Clinical Trials Insight By Company, Indication and Phase
9.1 8.1 Research
9.2 8.2 Preclinical
9.3 8.3 Clinical
9.4 8.4 Phase-I
9.5 8.5 Phase-I/II
9.6 8.6 Phase-II
9.7 8.7 Phase-III/II
9.8 8.8 Phase-III
9.9 8.9 Preregistration
9.10 8.10 Registered

10. Marketed Cancer Vaccines Clinical Insight By Company and Indication

11. Competitive Landscape
11.1 10.1 Anixa Bioscience
11.2 10.2 Argos Therapeutics
11.3 10.3 AstraZeneca
11.4 10.4 BioNTech
11.5 10.5 Bristol Myers Squibb
11.6 10.6 Champions Oncology
11.7 10.7 CureVac
11.8 10.8 Elicio Therapeutics
11.9 10.9 ETheRNA
11.10 10.10 GlaxoSmithKline
11.11 10.11 ImmunityBio
11.12 10.12 Imugene
11.13 10.13 In3Bio
11.14 10.14 Merck
11.15 10.15 Mayo Clinic
11.16 10.16 Nykode Therapeutics
11.17 10.17 Regeneron?
11.18 10.18 Roche
11.19 10.19 TVAX Biomedical
11.20 10.20 UbiVac
11.21 10.21 Ultimovacs
11.22 10.22 VBI vaccines

List of Figures & Tables
Figure 1-1: Categorization and Function of Cancer Vaccines
Figure 2-1: Classification of Different Types of Cancer vaccines
Figure 3-1: Global - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 3-2: Cancer Vaccine - Market Size by Region (US$ Million), 2021
Figure 3-3: Cancer Vaccine - Market Size by Region (%), 2021
Figure 3-4: Global - Cancer Vaccine Market Size (US$ Billion), 2022 - 2028
Figure 4-1: US - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-2: US vs. ROW - Cancer Vaccine Market Size (US$ Million), 2021
Figure 4-3: US vs. ROW - Cancer Vaccine Market Size (%), 2021
Figure 4-4: US - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-5: Europe - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-6: Europe vs. ROW - Cancer Vaccine Market Size (US$ Million), 2021
Figure 4-7: Europe vs. ROW - Cancer Vaccine Market Size (%), 2021
Figure 4-8: Europe - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-9: China - Market Share of HPV Vaccine Suppliers (%), 2020
Figure 4-10: China - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-11: China - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-12: Japan - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-13: Japan - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-14: India - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-15: India - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-16: South Korea - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-17: South Korea - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-18: Australia - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-19: Australia - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-20: Cuba - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-21: Cuba - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-22: Canada - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-23: Canada - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 4-24: UK - Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 4-25: UK - Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-1: Global - HPV Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 5-2: Global - HPV Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-3: Global - Lung Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 5-4: Global - Lung Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-5: Global - Pancreatic Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 5-6: Global - Pancreatic Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-7: Global - Prostate Cancer Vaccine Market Size (US$ Million), 2020 and 2021
Figure 5-8: Global - Prostate Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-9: Global - Bladder Cancer Vaccine Market Size (US$ Million), 2022 - 2028
Figure 5-10: Global - Melanoma Vaccine Market Size (US$ Million), 2025 - 2028
Figure 5-11: Global - Breast Cancer Vaccine Market Size (US$ Million), 2024 - 2028
Figure 5-12: Global - Colorectal Cancer Vaccine Market Size (US$ Million), 2025 - 2028
Figure 5-13: Global - Glioblastoma Vaccine Market Size (US$ Million), 2025 - 2028
Figure 5-14: Global - Ovarian Cancer Vaccine Market Size (US$ Million), 2025 - 2028
Figure 6-1: Gardasil - Approval Year by Region
Figure 6-2: Gardasil 9 - Approval Year by Region
Figure 6-3: US - Gardasil Approval Year by Indication
Figure 6-4: Canada - Gardasil Approval Year by Indication
Figure 6-5: Gardasil 9 - Patent Expiration Year by Region
Figure 6-6: US - Cost of 5ml and Per Unit Cost of Gardasil 9 Intramuscular Suspension (US$), July’2022
Figure 6-7: UK - Per Unit Cost of Gardasil and Gardasil 9 Injection (GBP/US$), July’2022
Figure 6-8: South Korea - Per Unit Cost of Gardasil Injection (KRW/US$), July’2022
Figure 6-9: Global - Gardasil/ Gardasil 9 Sales Value (US$ Million), Q1’2021 and Q1’2022
Figure 6-10: Global - Gardasil/ Gardasil 9 Sales Value (US$ Million), 2018 - 2021
Figure 6-11: Global - Gardasil/ Gardasil 9 Quarterly Sales Value (US$ Million), 2021
Figure 6-12: Global - Gardasil/ Gardasil 9 Quarterly Sales Value (US$ Million), 2020
Figure 6-13: Cervarix - Approval Year by Region
Figure 6-14: UK - Per Unit Cost of Cervarix Injection (GBP/US$), July’2022
Figure 6-15: UK - Cost of Single Cycle and Total Cost of Treatment with Cervarix (GBP/US$), July’2022
Figure 6-16: South Korea - Per Unit Cost of Cervarix Injection (KRW/US$), July’2022
Figure 6-17: Cervarix - Sales Value by Region (Euro/US$ Million), Q1’2022
Figure 6-18: Cervarix - Sales Value by Region (%), Q1’2022
Figure 6-19: Global - Cervarix Sales Value (Euro/US$ Million), 2019 - 2021
Figure 6-20: Europe - Cervarix Sales Value (Euro/US$ Million), 2019 - 2021
Figure 6-21: Cervarix - Sales Value by Region (Euro/US$ Million), 2021
Figure 6-22: Cervarix - Sales Value by Region (%), 2021
Figure 6-23: US - Cost of 250ml and Per Unit Cost of Proenge Intraveneous Suspension (US$), July’2022
Figure 6-24: India - Per Unit Cost of Mycidac-C Injection (INR/US$), July’2022
Figure 7-1: Global - Number of Cancer Vaccines in Clinical Trials by Company, 2022 till 2028
Figure 7-2: Global - Number of Cancer Vaccines in Clinical Trials by Country, 2022 till 2028
Figure 7-3: Global - Number of Cancer Vaccines Clinical Trials by Disease Stage, 2022 till 2028
Figure 7-4: Global - Number of Cancer Vaccine in Clinical Trials by Phase, 2022 till 2028